News
Through nifty marketing and an insurance-circumventing subscription model that delivers medicine directly to your front door, ...
Tesla ( TSLA) was the best-performing stock in the S&P 500 as the feud between CEO Elon Musk and President Donald Trump that ...
Hims & Hers Health has a better P/E ratio of 77.6 than the aggregate P/E ratio of 48.44 of the Health Care Providers & ...
New applications for jobless benefits rose by 8,000 to 247,000 for the week ending May 31, the Department of Labor announced ...
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
Hims & Hers Health has seen massive success, aided by the growing use of GLP-1 drugs. Click here to find out why I downgrade ...
Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...
The health sector is bustling with activity as Hims & Hers expands internationally, Trump’s tax-cut bill potentially ...
Hims & Hers (HIMS) doubles revenue, expands margins, and grows subscribers. Zava acquisition triples market potential, ...
Hims & Hers is acquiring digital health provider ZAVA to expand into Europe, aiming to boost revenue and international market ...
Zava has operated in Europe since 2011, preceding Hims by six years. It is a private company, corporately Health Bridge Limited, registered with Companies House in London, and the UK company was ...
Telehealth platform Hims & Hers is set to acquire UK startup Zava to strengthen its international presence. Meanwhile, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results